Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Wu TC, Shen YC, Cheng AL. Evolution of systemic treatment for advanced hepatocellular carcinoma. Kaohsiung J Med Sci, 2021;37(8):643–53.

Article  PubMed  Google Scholar 

Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev, 2011;91(3):1071–121.

Article  PubMed  CAS  Google Scholar 

Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, Ribatti D. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic. Curr Med Chem, 2006;13(16):1845–57.

Article  PubMed  CAS  Google Scholar 

Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med, 2020;382(20):1894–905.

Article  PubMed  CAS  Google Scholar 

Fan T, Li S, Li K, Xu J, Zhao S, Li J, Zhou X, Jiang H. A potential prognostic marker for recognizing VEGF-Positive hepatocellular carcinoma based on magnetic resonance radiomics signature. Front Oncol, 2022;12:857715.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012;48(4):441–6.

Article  PubMed  PubMed Central  Google Scholar 

Gong XQ, Tao YY, Wu YK, Liu N, Yu X, Wang R, Zheng J, Liu N, Huang XH, Li JD et al. Progress of MRI radiomics in hepatocellular carcinoma. Front Oncol, 2021;11:698373.

Article  PubMed  PubMed Central  Google Scholar 

Zheng J, Du PZ, Yang C, Tao YY, Li L, Li ZM, Yang L. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma. Abdom Radiol (NY), 2023;48(11):3343–52.

Article  PubMed  Google Scholar 

Tao YY, Shi Y, Gong XQ, Li L, Li ZM, Yang L, Zhang XM. Radiomic analysis based on magnetic resonance imaging for predicting PD-L2 expression in hepatocellular carcinoma. Cancers (Basel), 2023;15(2).

Gong XQ, Liu N, Tao YY, Li L, Li ZM, Yang L, Zhang XM. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma. Sci Rep, 2023;13(1):7710.

Article  PubMed  CAS  Google Scholar 

Yang C, Wei X, Zheng J, Tao Y, Gong X, Li L, Li Z, Yang L, Mao Q, Zhou M et al. A correlative study between IVIM-DWI parameters and VEGF and MMPs expression in hepatocellular carcinoma. Quant Imag Med Surg, 2022:0–0.

Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol 1990;21(6):607–12.

Article  PubMed  CAS  Google Scholar 

Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D et al. Radiomics: The process and the challenges. Magn Reson Imaging, 2012;30(9):1234–48.

Article  PubMed  Google Scholar 

Caballo M, Boone JM, Mann R, Sechopoulos I. An unsupervised automatic segmentation algorithm for breast tissue classification of dedicated breast computed tomography images. Med Phys, 2018;45(6):2542–59.

Article  PubMed  Google Scholar 

Haniff N, Abdul KM, Osman NH, Saripan MI, Che II, Ibahim MJ. Stability and reproducibility of radiomic features based various segmentation technique on MR images of hepatocellular carcinoma (HCC). Diagnostics (Basel), 2021;11(9).

Qiu Q, Duan J, Duan Z, Meng X, Ma C, Zhu J, Lu J, Liu T, Yin Y. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: Impact of tumor segmentation variability. Quant Imaging Med Surg, 2019;9(3):453–64.

Article  PubMed  Google Scholar 

Muppala S. Growth Factor-Induced angiogenesis in hepatocellular carcinoma. Crit Rev Oncog, 2021;26(1):61–8.

Article  PubMed  Google Scholar 

Yadav L, Puri N, Rastogi V, Satpute P, Sharma V. Tumour angiogenesis and angiogenic inhibitors: A review. J Clin Diagn Res, 2015;9(6):E1-5.

Google Scholar 

Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol, 1998;153(1):11–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, Finn RS. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res, 2019;25(3):912–20.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Liu P, Jiang Y, Dou X, Yan J, Ma C, Fan Q, Wang W, Su F, Tang H et al. High expression of neuropilin-1 associates with unfavorable clinicopathological features in hepatocellular carcinoma. Pathol Oncol Res, 2016;22(2):367–75.

Article  PubMed  CAS  Google Scholar 

Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA. Background, current role, and potential applications of radiogenomics. J Magn Reson Imaging, 2018;47(3):604–20.

Article  PubMed  Google Scholar 

Hectors SJ, Lewis S, Besa C, King MJ, Said D, Putra J, Ward S, Higashi T, Thung S, Yao S et al. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma. Eur Radiol, 2020;30(7):3759–69.

Article  PubMed  PubMed Central  Google Scholar 

Gu D, Xie Y, Wei J, Li W, Ye Z, Zhu Z, Tian J, Li X. MRI-Based radiomics signature: A potential biomarker for identifying glypican 3-Positive hepatocellular carcinoma. J Magn Reson Imaging, 2020;52(6):1679–87.

Article  PubMed  Google Scholar 

Wang L, Ma X, Feng B, Wang S, Liang M, Li D, Wang S, Zhao X. Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤ 5 cm. Front Oncol, 2022;12:899404.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hui T, Chuah TK, Low HM, Tan CH. Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: A radiomics study. Clin Radiol, 2018;73(12):1011–56.

Article  Google Scholar 

Li Y, Yan C, Weng S, Shi Z, Sun H, Chen J, Xu X, Ye R, Hong J. Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma. Clin Radiol, 2019;74(10):813–9.

Article  Google Scholar 

Zhang R, Xu L, Wen X, Zhang J, Yang P, Zhang L, Xue X, Wang X, Huang Q, Guo C et al. A nomogram based on bi-regional radiomics features from multimodal magnetic resonance imaging for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Quant Imaging Med Surg, 2019;9(9):1503–15.

Article  PubMed  PubMed Central  Google Scholar 

Yuan G, Song Y, Li Q, Hu X, Zang M, Dai W, Cheng X, Huang W, Yu W, Chen M et al. Development and validation of a Contrast-Enhanced CT-Based radiomics nomogram for prediction of therapeutic efficacy of Anti-PD-1 antibodies in advanced HCC patients. Front Immunol, 2020;11:613946.

Article  PubMed  CAS  Google Scholar 

Wang XH, Long LH, Cui Y, Jia AY, Zhu XG, Wang HZ, Wang Z, Zhan CM, Wang ZH, Wang WH. MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer, 2020;122(7):978–85.

Article  PubMed  CAS  Google Scholar 

Granito A, Galassi M, Piscaglia F, Romanini L, Lucidi V, Renzulli M, Borghi A, Grazioli L, Golfieri R, Bolondi L. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: A prospective study. Aliment Pharmacol Ther, 2013;37(3):355–63.

Article  PubMed  CAS  Google Scholar